Education

Dr. M. Soledad Orellano received her Bachelor Degree in Chemistry from the National University of Rio Cuarto (Argentina). In 2014 she obtained a Ph.D. fellowship funded by the Argentinean National Council of Scientific and Technical Research (CONICET). She worked on the synthesis of chitosan nanoparticles using different reverse micelles systems as nanoreactors. Also, she studied the antimicrobial and antibiofilm activity of these nanoparticles against bovine mastitis pathogens, as well their interaction with bovine cells in vitro. Her thesis work was performed at the National University of Villa Maria (Argentina) under the supervision of Prof. Carina Porporatto and Prof. R. Dario Falcone. She received her Ph.D. degree in 2019 from the National University of Rio Cuarto (Argentina).
In 2018 she obtained a Fulbright grant to carry out an internship for three months at the University of Tennessee, Knoxville, United States under the supervision of Prof. Raul A. Almeida. She worked on the antimicrobial activity of chitosan nanoparticles against intracellular Staphylococcus aureus using in vitro mammary gland model.
In 2019 she obtained a postdoctoral fellowship funded by CONICET to perform postdoctoral training at the National University of Rio Cuarto (Argentina) under the supervision of Prof. N. Mariano Correa. She worked on the synthesis of chitosan-based polymeric surfactants and the physicochemical characterization of polymeric micelles using fluorescence molecular probes.

Research

Since March 2021 she joined the Responsive Polymer Therapeutics Group as a postdoctoral researcher through a Marie Skłodowska-Curie individual fellowship under the supervision of Prof. Marcelo Calderón. Her research work is focused on the development of nanogels with thermoresponsive and mucoadhesive properties for the delivery of antimicrobials into the bovine udder. Her research interests are related to the use of smart nanomaterials to treat bacterial infections, overcoming the failure of antimicrobial treatments currently used.

Responsive Polymer Therapeutics Group

Publications